查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2128121

數位PCR市場規模、佔有率、成長、全球產業分析、區域趨勢及2026年至2034年預測。

Digital PCR Market Size, Share, Growth and Global Industry Analysis, Regional Insights and Forecast to 2026-2034
出版日期: | 出版商: Fortune Business Insights Pvt. Ltd. | 英文 130 Pages | 商品交期: 2-3個工作天內

價格

數位PCR市場成長要素

全球數位PCR市場預計到2025年將達到8.572億美元，從2026年的10.432億美元成長到2034年的57.7673億美元，預測期內複合年成長率（CAGR）為23.90%。北美市場將引領全球市場，預計到2025年將佔43.70%的市場佔有率，這主要得益於北美地區對先進分子診斷技術的早期應用、充足的研究經費以及精準醫療技術的廣泛應用。

數位聚合酵素鏈鎖反應(dPCR) 是一種先進的分子診斷技術，能夠對 DNA 和 RNA 分子進行高精度、絕對定量。與傳統 PCR 和即時PCR相比，數位 PCR 具有更高的靈敏度、準確性和可重複性，並且能夠檢測罕見的基因突變。感染疾病、癌症和遺傳性疾病的日益流行，以及分子診斷領域投資的不斷成長和技術的持續創新，正在推動全球市場擴張。到 2034 年，臨床檢查室、製藥公司、生物技術公司和研究機構對數位 PCR 的日益普及將進一步加速該產業的成長。

市場促進因素

感染疾病和癌症發病率的上升正在推動產品需求。

隨著感染疾病、癌症和遺傳性疾病發生率的不斷上升，對高靈敏度分子診斷技術的需求顯著成長。數位PCR技術能夠精確檢測低濃度核酸，因此非常適合用於疾病早期診斷、液態生物檢體、突變分析和感染疾病檢測。

由於數位PCR無需標準曲線即可進行絕對定量，且比傳統PCR方法具有更高的準確性，因此醫療專業人員正擴大採用數位PCR技術。這項技術已成為精準醫療、個人化治療計畫制定和進階臨床研究的重要工具。

持續的技術創新推動市場成長。

領先的製造商正在陸續推出下一代數位 PCR 平台，這些平台具有更高的自動化程度、多重分析能力、更快的工作流程和更高的靈敏度。

例如，2022年11月，深圳市努氏生物醫學工程有限公司推出了「Molecision S6數位PCR系統」，這是一個用於研發和體外診斷的全自動整合平台。同樣，Bio-Rad、Thermo Fisher Scientific、QIAGEN和Roche等公司也透過推出創新儀器和開發試劑，不斷拓展產品系列。

這些技術進步正在擴大數位 PCR 的應用領域，例如腫瘤學、傳染病檢查、產前篩檢、移植監測和基因研究。

市場限制因素

儘管數位PCR系統具有許多優勢，但與傳統PCR技術相比，其成本仍然較高。高昂的設備成本、耗材費用以及對訓練有素的實驗室人員的需求，持續限制數位PCR系統的普及應用，尤其是在開發中國家。

此外，諸如次世代定序（NGS）等基因組分析替代技術的日益普及加劇了競爭壓力。低收入地區先進實驗室基礎設施和微流體技術的匱乏也進一步阻礙了市場滲透。

市場機遇

對精準醫療、伴隨診斷和個人化醫療的投資增加，為數位PCR設備製造商創造了巨大的機會。生技公司、診斷設備製造商和研究機構之間合作的加強，正在加速產品的商業化進程。

在亞太和拉丁美洲等新興市場，醫療基礎設施的顯著改善正在創造新的商機。政府對分子診斷能力的支持以及對先進傳染病檢查日益成長的需求，預計將進一步推動市場長期成長。

市場趨勢

向晶片式數位PCR技術過渡

塑造市場格局的關鍵趨勢之一是從基於液滴的數位PCR系統逐步過渡到基於晶片的平台。基於晶片的系統減少了人工檢體處理，最大限度地降低了污染風險，提高了實驗的可重複性，並簡化了檢查室工作流程。

由於晶片技術具有處理速度更快、精度更高、操作更簡單且成本效益更高等優點，醫療服務提供者正日益青睞此類技術。預計這一轉變將推動產品創新，並加速其在研究和臨床領域的應用。

市場區隔

按類型分類，液滴數位PCR (ddPCR) 預計在2026年仍將保持領先地位，佔全球市場82.04%的佔有率，這主要得益於其卓越的靈敏度以及在感染疾病診斷中日益廣泛的應用。隨著自動化分子檢測平台在檢查室中的應用日益普及，晶片式數位PCR預計也將保持穩定成長。

按產品類別分類，預計到2026年，儀器將佔市場佔有率的59.01%，這主要得益於新產品的不斷推出和檢查室採用率的不斷提高。同時，隨著全球檢測數量的持續成長，試劑和耗材預計將實現最高的成長率。

從適應症來看，預計到 2026 年，遺傳性疾病將佔全球銷售額的 51.56%，而癌症和感染疾病領域的應用預計將在精準醫療和分子診斷技術的進步推動下強勁成長。

按最終用戶分類，預計到2026年，學術和研究機構將主導市場，佔67.90%的市場佔有率，這反映了癌症基因組學、感染疾病和分子生物學領域研究活動的擴展。同時，臨床檢查室預計在預測期內將經歷最快的成長。

區域展望

預計北美地區2025年的銷售額將達到3.7468億美元，2026年將達到4.5647億美元。這得益於該地區持續的主導地位，而這又得益於強大的研究基礎設施、檢查室中先進技術的應用以及主要行業參與者的存在。

在歐洲，預計到 2025 年市場規模將達到 2.3475 億美元，到 2026 年將達到 2.8345 億美元。政府對分子診斷的投資增加、研究經費的擴大以及有利的醫療保健政策將繼續支持該地區的市場成長。

預計亞太地區市場規模將在 2025 年達到 1.8756 億美元，並在 2026 年成長至 2.3164 億美元。醫療保健投資的增加、診斷能力的擴大、感染疾病負擔的加重以及檢查室基礎設施的改善，正在推動中國、日本、印度和其他新興經濟體市場的快速擴張。

預計到2025年，拉丁美洲市場規模將達到3,237萬美元，而中東和非洲市場規模將達到2,781萬美元。由於醫療保健現代化進程的推進和先進分子診斷技術的商業化，這些地區的市場滲透率預計將逐步提高。

近期產業發展動態包括：QIAGEN 擴大其數位 PCR 試劑盒產品線，Thermo Fisher 推出先進的數位 PCR 研究解決方案，Bio-Rad 透過收購加強其分子診斷能力，以及 Stilla 擴大其全球銷售夥伴關係以擴大其市場覆蓋範圍。

2026 年至 2034 年的複合年成長率為 23.90%。

目錄

第1章：引言

第2章摘要整理

第3章 市場動態

  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場趨勢

第4章：主要考慮因素

  • 2025年主要國家和地區慢性病（癌症和感染疾病）盛行率
  • 產業重大發展動態：合併、收購、合作等。
  • 主要國家和地區的監管趨勢
  • 數位PCR技術的進步
  • 新冠疫情對市場的影響

第5章：2021-2034年全球數位PCR市場分析、洞察與預測

  • 市場分析、洞察與預測：按類型
    • 液滴式數位PCR
    • 晶片式數位PCR
    • 其他
  • 市場分析、洞察與預測：按產品分類。
    • 裝置
    • 試劑和耗材
  • 市場分析、洞察與預測：按指標
    • 感染疾病
    • 腫瘤學
    • 遺傳性疾病
    • 其他
  • 市場分析、洞察與預測：按最終用戶分類
    • 醫院和診所
    • 製藥和生物技術產業
    • 臨床實驗室
    • 學術和研究機構
  • 市場分析、洞察與預測：按地區分類
    • 北美洲
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東和非洲

第6章：北美數位PCR市場分析、洞察與預測（2021-2034年）

  • 國家
    • 美國
    • 加拿大

第7章：歐洲數位PCR市場分析、洞察與預測（2021-2034年）

  • 國家
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 斯堪地那維亞
    • 其他歐洲國家

第8章：亞太地區數位PCR市場分析、洞察與預測（2021-2034年）

  • 國家
    • 中國
    • 日本
    • 印度
    • 澳洲
    • 東南亞
    • 其他亞太國家

第9章：拉丁美洲數位PCR市場分析、洞察與預測（2021-2034年）

  • 國家
    • 巴西
    • 墨西哥
    • 其他拉丁美洲國家

第10章：中東和非洲數位PCR市場分析、洞察與預測（2021-2034年）

  • 國家
    • GCC
    • 南非
    • 其他中東和非洲國家

第11章 競爭分析

  • 全球市佔率分析（2025 年）
  • 公司簡介
    • QIAGEN
    • Thermo Fisher Scientific Inc.
    • Bio-Rad Laboratories, Inc.
    • JN Medsys
    • Stilla
    • Sysmex Corporation
    • Standard BioTools Inc.
    • Precigenome LLC.
Product Code: FBI102014

Growth Factors of digital PCR Market

The global digital PCR market was valued at USD 857.2 million in 2025 and is projected to grow from USD 1,043.20 million in 2026 to USD 5,776.73 million by 2034, registering a CAGR of 23.90% during the forecast period. North America dominated the global market with a 43.70% market share in 2025, driven by early adoption of advanced molecular diagnostics, strong research funding, and widespread use of precision medicine technologies.

Digital polymerase chain reaction (dPCR) is an advanced molecular diagnostic technology that enables highly accurate and absolute quantification of DNA and RNA molecules. Compared to conventional PCR and real-time PCR, digital PCR offers superior sensitivity, precision, reproducibility, and the ability to detect rare genetic mutations. The growing prevalence of infectious diseases, cancer, and genetic disorders, coupled with increasing investments in molecular diagnostics and continuous technological innovations, is driving market expansion worldwide. The increasing adoption of digital PCR across clinical laboratories, pharmaceutical companies, biotechnology firms, and research organizations is further accelerating industry growth through 2034.

Market Drivers

Rising Prevalence of Infectious Diseases and Cancer Driving Product Demand

The increasing incidence of infectious diseases, oncology cases, and inherited genetic disorders has significantly increased the demand for highly sensitive molecular diagnostic technologies. Digital PCR enables precise detection of low-abundance nucleic acids, making it highly suitable for early disease diagnosis, liquid biopsy, mutation analysis, and infectious disease detection.

Healthcare providers are increasingly adopting digital PCR due to its ability to deliver absolute quantification without requiring standard curves while providing greater accuracy than conventional PCR methods. The technology has become an essential tool for precision medicine, personalized treatment planning, and advanced clinical research.

Continuous Technological Advancements Supporting Market Growth

Leading manufacturers continue introducing next-generation digital PCR platforms with improved automation, multiplexing capabilities, faster workflows, and enhanced sensitivity.

For example, in November 2022, Shenzhen New Industries Biomedical Engineering launched the Molecision S6 Digital PCR System, offering a fully automated integrated platform for research and in-vitro diagnostics. Similarly, Bio-Rad, Thermo Fisher Scientific, QIAGEN, and Roche continue expanding their product portfolios through innovative instrument launches and reagent development.

These technological improvements are expanding digital PCR applications across oncology, infectious disease testing, prenatal screening, transplant monitoring, and genetic research.

Market Restraints

Despite its advantages, digital PCR systems remain expensive compared to conventional PCR technologies. High equipment costs, costly consumables, and the requirement for trained laboratory personnel continue limiting adoption, particularly in developing countries.

In addition, the growing availability of alternative technologies such as next-generation sequencing (NGS) for genomic analysis creates competitive pressure. Limited accessibility to advanced laboratory infrastructure and microfluidic technologies further restrains market penetration in low-income regions.

Market Opportunities

Growing investments in precision medicine, companion diagnostics, and personalized healthcare are creating substantial opportunities for digital PCR manufacturers. Increasing collaborations between biotechnology companies, diagnostic manufacturers, and research institutions are accelerating product commercialization.

Emerging markets across Asia Pacific and Latin America are witnessing significant healthcare infrastructure improvements, creating new revenue opportunities. Government support for molecular diagnostic capabilities and increasing demand for advanced infectious disease testing are expected to further strengthen long-term market growth.

Market Trends

Shift Toward Chip-Based Digital PCR Technology

One of the major trends shaping the market is the gradual shift from droplet-based digital PCR systems to chip-based platforms. Chip-based systems reduce manual sample handling, minimize contamination risks, improve reproducibility, and simplify laboratory workflows.

Healthcare providers increasingly prefer chip-based technologies due to their faster processing, improved accuracy, lower operational complexity, and cost efficiency. This transition is expected to drive product innovation and increase adoption across both research and clinical settings.

Market Segmentation

By type, droplet digital PCR (ddPCR) is expected to remain the dominant segment in 2026, accounting for 82.04% of the global market due to its superior sensitivity and increasing use in infectious disease diagnostics. Chip-based digital PCR is projected to witness steady growth as laboratories increasingly adopt automated molecular testing platforms.

Based on product, instruments are expected to account for 59.01% of the market in 2026, supported by continuous product launches and increasing laboratory installations. Meanwhile, reagents and consumables are anticipated to record the fastest growth as testing volumes continue rising globally.

By indication, genetic disorders are projected to contribute 51.56% of global revenue in 2026, while oncology and infectious disease applications are expected to experience strong expansion driven by precision medicine and molecular diagnostics.

Based on end user, academic and research organizations are projected to dominate the market with 67.90% share in 2026, reflecting growing research activities involving cancer genomics, infectious diseases, and molecular biology. Clinical laboratories are expected to witness the fastest growth during the forecast period.

Regional Outlook

North America generated USD 374.68 million in 2025 and is expected to reach USD 456.47 million in 2026, maintaining its leadership due to strong research infrastructure, advanced laboratory adoption, and the presence of major industry participants.

Europe recorded USD 234.75 million in 2025 and is projected to reach USD 283.45 million in 2026. Increasing government investments in molecular diagnostics, expanding research funding, and favorable healthcare policies continue supporting regional market growth.

Asia Pacific reached USD 187.56 million in 2025 and is forecast to grow to USD 231.64 million in 2026. Rising healthcare investments, expanding diagnostic capabilities, growing infectious disease burden, and improving laboratory infrastructure are fueling rapid market expansion across China, Japan, India, and other emerging economies.

Latin America generated USD 32.37 million in 2025, while the Middle East & Africa accounted for USD 27.81 million. Growing healthcare modernization initiatives and increasing commercialization of advanced molecular diagnostic technologies are expected to gradually improve market penetration across these regions.

Competitive Landscape

The global digital PCR market remains highly consolidated, with major players focusing on technological innovation, acquisitions, product launches, and strategic collaborations to strengthen their competitive position.

Leading companies include Bio-Rad Laboratories, Inc., Thermo Fisher Scientific Inc., QIAGEN, JN Medsys, Stilla, Sysmex Corporation, Standard BioTools Inc., and Precigenome LLC.

Recent industry developments include QIAGEN expanding its digital PCR kit portfolio, Thermo Fisher introducing advanced digital PCR research solutions, Bio-Rad strengthening its molecular diagnostics capabilities through acquisitions, and Stilla expanding global distribution partnerships to increase market reach.

Conclusion

The digital PCR market is expected to witness exceptional growth between 2026 and 2034, driven by increasing demand for precision diagnostics, continuous technological innovation, expanding applications in oncology and infectious diseases, and rising investments in molecular biology research. Strong adoption across clinical laboratories, pharmaceutical companies, and research institutions, combined with growing healthcare infrastructure in emerging economies, will continue supporting long-term global market expansion.

Growth Rate CAGR of 23.90% from 2026-2034

Segmentation

By Type

  • Droplet Digital PCR
  • Chip-based Digital PCR
  • Others

By Product

  • Instruments
  • Reagents & Consumables

By Indication

  • Infectious Diseases
  • Oncology
  • Genetic Disorders
  • Others

By End-user

  • Hospitals & Clinics
  • Pharmaceutical & Biotechnology Industries
  • Clinical Laboratories
  • Academic & Research Organizations

By Geography

  • North America (By Type, Product, By Indication, End-user, and Country)
    • U.S.
    • Canada
  • Europe (By Type, Product, By Indication, End-user, and Country/ Sub-region)
    • U.K.
    • Germany
    • France
    • Italy
    • Spain
    • Scandinavia
    • Rest of Europe
  • Asia Pacific (By Type, Product, By Indication, End-user, and Country/Sub-region)
    • China
    • Japan
    • India
    • Australia
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America (By Type, Product, By Indication, End-user, and Country/ Sub-region)
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa (By Type, Product, By Indication, End-user, and Country/ Sub-region)
    • GCC
    • South Africa
    • Rest of Middle East & Africa

Table of Content

1. Introduction

  • 1.1. Research Scope
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
  • 1.4. Definitions and Assumptions

2. Executive Summary

3. Market Dynamics

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Market Trends

4. Key Insights

  • 4.1. Prevalence of Chronic Diseases (Cancer and Infectious Disease), By Key Countries/Regions, 2025
  • 4.2. Key Industry Developments - Mergers, Acquisitions, Partnerships, etc.
  • 4.3. Regulatory Scenario, By Key Countries/Region
  • 4.4. Technological Advancements in Digital PCR
  • 4.5. Impact of Covid-19 on the Market

5. Global Digital PCR Market Analysis, Insights and Forecast, 2021-2034

  • 5.1. Market Analysis, Insights and Forecast - By Type
    • 5.1.1. Droplet Digital PCR
    • 5.1.2. Chip-based Digital PCR
    • 5.1.3. Others
  • 5.2. Market Analysis, Insights and Forecast - By Product
    • 5.2.1. Instruments
    • 5.2.2. Reagents & Consumables
  • 5.3. Market Analysis, Insights and Forecast - By Indication
    • 5.3.1. Infectious Diseases
    • 5.3.2. Oncology
    • 5.3.3. Genetic Disorders
    • 5.3.4. Others
  • 5.4. Market Analysis, Insights and Forecast - By End-user
    • 5.4.1. Hospitals & Clinics
    • 5.4.2. Pharmaceutical & Biotechnology Industries
    • 5.4.3. Clinical Laboratories
    • 5.4.4. Academic & Research Organisations
  • 5.5. Market Analysis, Insights and Forecast - By Geography
    • 5.5.1. North America
    • 5.5.2. Europe
    • 5.5.3. Asia Pacific
    • 5.5.4. Latin America
    • 5.5.5. Middle East & Africa

6. North America Digital PCR Market Analysis, Insights and Forecast, 2021-2034

  • 6.1. Market Analysis, Insights and Forecast - By Type
    • 6.1.1. Droplet Digital PCR
    • 6.1.2. Chip-based Digital PCR
    • 6.1.3. Others
  • 6.2. Market Analysis, Insights and Forecast - By Product
    • 6.2.1. Instruments
    • 6.2.2. Reagents & Consumables
  • 6.3. Market Analysis, Insights and Forecast - By Indication
    • 6.3.1. Infectious Diseases
    • 6.3.2. Oncology
    • 6.3.3. Genetic Disorders
    • 6.3.4. Others
  • 6.4. Market Analysis, Insights and Forecast - By End-user
    • 6.4.1. Hospitals & Clinics
    • 6.4.2. Pharmaceutical & Biotechnology Industries
    • 6.4.3. Clinical Laboratories
    • 6.4.4. Academic & Research Organisations
  • 6.5. Market Analysis, Insights and Forecast - By Country
    • 6.5.1. U.S.
    • 6.5.2. Canada

7. Europe Digital PCR Market Analysis, Insights and Forecast, 2021-2034

  • 7.1. Market Analysis, Insights and Forecast - By Type
    • 7.1.1. Droplet Digital PCR
    • 7.1.2. Chip-based Digital PCR
    • 7.1.3. Others
  • 7.2. Market Analysis, Insights and Forecast - By Product
    • 7.2.1. Instruments
    • 7.2.2. Reagents & Consumables
  • 7.3. Market Analysis, Insights and Forecast - By Indication
    • 7.3.1. Infectious Diseases
    • 7.3.2. Oncology
    • 7.3.3. Genetic Disorders
    • 7.3.4. Others
  • 7.4. Market Analysis, Insights and Forecast - By End-user
    • 7.4.1. Hospitals & Clinics
    • 7.4.2. Pharmaceutical & Biotechnology Industries
    • 7.4.3. Clinical Laboratories
    • 7.4.4. Academic & Research Organisations
  • 7.5. Market Analysis, Insights and Forecast - By Country/ Sub-region
    • 7.5.1. U.K.
    • 7.5.2. Germany
    • 7.5.3. France
    • 7.5.4. Italy
    • 7.5.5. Spain
    • 7.5.6. Scandinavia
    • 7.5.7. Rest of Europe

8. Asia Pacific Digital PCR Market Analysis, Insights and Forecast, 2021-2034

  • 8.1. Market Analysis, Insights and Forecast - By Type
    • 8.1.1. Droplet Digital PCR
    • 8.1.2. Chip-based Digital PCR
    • 8.1.3. Others
  • 8.2. Market Analysis, Insights and Forecast - By Product
    • 8.2.1. Instruments
    • 8.2.2. Reagents & Consumables
  • 8.3. Market Analysis, Insights and Forecast - By Indication
    • 8.3.1. Infectious Diseases
    • 8.3.2. Oncology
    • 8.3.3. Genetic Disorders
    • 8.3.4. Others
  • 8.4. Market Analysis, Insights and Forecast - By End-user
    • 8.4.1. Hospitals & Clinics
    • 8.4.2. Pharmaceutical & Biotechnology Industries
    • 8.4.3. Clinical Laboratories
    • 8.4.4. Academic & Research Organisations
  • 8.5. Market Analysis, Insights and Forecast - By Country/ Sub-region
    • 8.5.1. China
    • 8.5.2. Japan
    • 8.5.3. India
    • 8.5.4. Australia
    • 8.5.5. Southeast Asia
    • 8.5.6. Rest of APAC

9. Latin America Digital PCR Market Analysis, Insights and Forecast, 2021-2034

  • 9.1. Market Analysis, Insights and Forecast - By Type
    • 9.1.1. Droplet Digital PCR
    • 9.1.2. Chip-based Digital PCR
    • 9.1.3. Others
  • 9.2. Market Analysis, Insights and Forecast - By Product
    • 9.2.1. Instruments
    • 9.2.2. Reagents & Consumables
  • 9.3. Market Analysis, Insights and Forecast - By Indication
    • 9.3.1. Infectious Diseases
    • 9.3.2. Oncology
    • 9.3.3. Genetic Disorders
    • 9.3.4. Others
  • 9.4. Market Analysis, Insights and Forecast - By End-user
    • 9.4.1. Hospitals & Clinics
    • 9.4.2. Pharmaceutical & Biotechnology Industries
    • 9.4.3. Clinical Laboratories
    • 9.4.4. Academic & Research Organisations
  • 9.5. Market Analysis, Insights and Forecast - By Country/ Sub-region
    • 9.5.1. Brazil
    • 9.5.2. Mexico
    • 9.5.3. Rest of Latin America

10. Middle East & Africa Digital PCR Market Analysis, Insights and Forecast, 2021-2034

  • 10.1. Market Analysis, Insights and Forecast - By Type
    • 10.1.1. Droplet Digital PCR
    • 10.1.2. Chip-based Digital PCR
    • 10.1.3. Others
  • 10.2. Market Analysis, Insights and Forecast - By Product
    • 10.2.1. Instruments
    • 10.2.2. Reagents & Consumables
  • 10.3. Market Analysis, Insights and Forecast - By Indication
    • 10.3.1. Infectious Diseases
    • 10.3.2. Oncology
    • 10.3.3. Genetic Disorders
    • 10.3.4. Others
  • 10.4. Market Analysis, Insights and Forecast - By End-user
    • 10.4.1. Hospitals & Clinics
    • 10.4.2. Pharmaceutical & Biotechnology Industries
    • 10.4.3. Clinical Laboratories
    • 10.4.4. Academic & Research Organisations
  • 10.5. Market Analysis, Insights and Forecast - By Country/ Sub-region
    • 10.5.1. GCC
    • 10.5.2. South Africa
    • 10.5.3. Rest of Middle East & Africa

11. Competitive Analysis

  • 11.1. Global Market Share Analysis (2025)
  • 11.2. Company Profiles
    • 11.2.1. QIAGEN
      • 11.2.1.1. Overview
      • 11.2.1.2. Products
      • 11.2.1.3. SWOT
      • 11.2.1.4. Recent Developments
      • 11.2.1.5. Strategies
      • 11.2.1.6. Financials (based on availability)
    • 11.2.2. Thermo Fisher Scientific Inc.
      • 11.2.2.1. Overview
      • 11.2.2.2. Products
      • 11.2.2.3. SWOT
      • 11.2.2.4. Recent Developments
      • 11.2.2.5. Strategies
      • 11.2.2.6. Financials (based on availability)
    • 11.2.3. Bio-Rad Laboratories, Inc.
      • 11.2.3.1. Overview
      • 11.2.3.2. Products
      • 11.2.3.3. SWOT
      • 11.2.3.4. Recent Developments
      • 11.2.3.5. Strategies
      • 11.2.3.6. Financials (based on availability)
    • 11.2.4. JN Medsys
      • 11.2.4.1. Overview
      • 11.2.4.2. Products
      • 11.2.4.3. SWOT
      • 11.2.4.4. Recent Developments
      • 11.2.4.5. Strategies
      • 11.2.4.6. Financials (based on availability)
    • 11.2.5. Stilla
      • 11.2.5.1. Overview
      • 11.2.5.2. Products
      • 11.2.5.3. SWOT
      • 11.2.5.4. Recent Developments
      • 11.2.5.5. Strategies
      • 11.2.5.6. Financials (based on availability)
    • 11.2.6. Sysmex Corporation
      • 11.2.6.1. Overview
      • 11.2.6.2. Products
      • 11.2.6.3. SWOT
      • 11.2.6.4. Recent Developments
      • 11.2.6.5. Strategies
      • 11.2.6.6. Financials (based on availability)
    • 11.2.7. Standard BioTools Inc.
      • 11.2.7.1. Overview
      • 11.2.7.2. Products
      • 11.2.7.3. SWOT
      • 11.2.7.4. Recent Developments
      • 11.2.7.5. Strategies
      • 11.2.7.6. Financials (based on availability)
    • 11.2.8. Precigenome LLC.
      • 11.2.8.1. Overview
      • 11.2.8.2. Products
      • 11.2.8.3. SWOT
      • 11.2.8.4. Recent Developments
      • 11.2.8.5. Strategies
      • 11.2.8.6. Financials (based on availability)

List of Tables

  • Table 1: Global Digital PCR Market Revenue (USD million) Forecast, by Type, 2021-2034
  • Table 2: Global Digital PCR Market Revenue (USD million) Forecast, by Product, 2021-2034
  • Table 3: Global Digital PCR Market Revenue (USD million) Forecast, by Indication, 2021-2034
  • Table 4: Global Digital PCR Market Revenue (USD million) Forecast, by End-user, 2021-2034
  • Table 5: Global Digital PCR Market Revenue (USD million) Forecast, by Region, 2021-2034
  • Table 6: North America Digital PCR Market Revenue (USD million) Forecast, by Type, 2021-2034
  • Table 7: North America Digital PCR Market Revenue (USD million) Forecast, by Product, 2021-2034
  • Table 8: North America Digital PCR Market Revenue (USD million) Forecast, by Indication, 2021-2034
  • Table 9: North America Digital PCR Market Revenue (USD million) Forecast, by End-user, 2021-2034
  • Table 10: North America Digital PCR Market Revenue (USD million) Forecast, By Country, 2021-2034
  • Table 11: Europe Digital PCR Market Revenue (USD million) Forecast, by Type, 2021-2034
  • Table 12: Europe Digital PCR Market Revenue (USD million) Forecast, by Product, 2021-2034
  • Table 13: Europe Digital PCR Market Revenue (USD million) Forecast, by Indication, 2021-2034
  • Table 14: Europe Digital PCR Market Revenue (USD million) Forecast, by End-user, 2021-2034
  • Table 15: Europe Digital PCR Market Revenue (USD million) Forecast, By Country/ Sub-region, 2021-2034
  • Table 16: Asia Pacific Digital PCR Market Revenue (USD million) Forecast, by Type, 2021-2034
  • Table 17: Asia Pacific Digital PCR Market Revenue (USD million) Forecast, by Product, 2021-2034
  • Table 18: Asia Pacific Digital PCR Market Revenue (USD million) Forecast, by Indication, 2021-2034
  • Table 19: Asia Pacific Digital PCR Market Revenue (USD million) Forecast, by End-user, 2021-2034
  • Table 20: Asia Pacific Digital PCR Market Revenue (USD million) Forecast, By Country/ Sub-region, 2021-2034
  • Table 21: Latin America Digital PCR Market Revenue (USD million) Forecast, by Type, 2021-2034
  • Table 22: Latin America Digital PCR Market Revenue (USD million) Forecast, by Product, 2021-2034
  • Table 23: Latin America Digital PCR Market Revenue (USD million) Forecast, by Indication, 2021-2034
  • Table 24: Latin America Digital PCR Market Revenue (USD million) Forecast, by End-user, 2021-2034
  • Table 25: Latin America Digital PCR Market Revenue (USD million) Forecast, By Country/ Sub-region, 2021-2034
  • Table 26: Middle East & Africa Digital PCR Market Revenue (USD million) Forecast, by Type, 2021-2034
  • Table 27: Middle East & Africa Digital PCR Market Revenue (USD million) Forecast, by Product, 2021-2034
  • Table 28: Middle East & Africa Digital PCR Market Revenue (USD million) Forecast, by Indication, 2021-2034
  • Table 29: Middle East & Africa Digital PCR Market Revenue (USD million) Forecast, by End-user, 2021-2034
  • Table 30: Middle East & Africa Digital PCR Market Revenue (USD million) Forecast, By Country/ Sub-region, 2021-2034

List of Figures

  • Figure 1: Global Digital PCR Market Revenue Breakdown (USD million, %) by Region, 2025 & 2034
  • Figure 2: Global Digital PCR Market Value Share (%), by Type, 2025 & 2034
  • Figure 3: Global Digital PCR Market Value Share (%), by Product, 2025 & 2034
  • Figure 4: Global Digital PCR Market Value Share (%), by Indication, 2025 & 2034
  • Figure 5: Global Digital PCR Market Value Share (%), by End-user, 2025 & 2034
  • Figure 6: North America Digital PCR Market Revenue (USD million) Forecast, by Type, 2021-2034
  • Figure 7: North America Digital PCR Market Value (USD million), by Type, 2025 & 2034
  • Figure 8: North America Digital PCR Market Value Share (%), by Type, 2025
  • Figure 9: North America Digital PCR Market Value (USD million), by Product, 2025 & 2034
  • Figure 10: North America Digital PCR Market Value Share (%), by Product, 2025
  • Figure 11: North America Digital PCR Market Value (USD million), by Indication, 2025 & 2034
  • Figure 12: North America Digital PCR Market Value Share (%), by Indication, 2025
  • Figure 13: North America Digital PCR Market Value (USD million), by End-user, 2025 & 2034
  • Figure 14: North America Digital PCR Market Value Share (%), by End-user, 2025
  • Figure 15: North America Digital PCR Market Value (USD million), By Country, 2025 & 2034
  • Figure 16: North America Digital PCR Market Value Share (%), By Country, 2025
  • Figure 17: Europe Digital PCR Market Value (USD million), by Type, 2025 & 2034
  • Figure 18: Europe Digital PCR Market Value Share (%), by Type, 2025
  • Figure 19: Europe Digital PCR Market Value (USD million), by Product, 2025 & 2034
  • Figure 20: Europe Digital PCR Market Value Share (%), by Product, 2025
  • Figure 21: Europe Digital PCR Market Value (USD million), by Indication, 2025 & 2034
  • Figure 22: Europe Digital PCR Market Value Share (%), by Indication, 2025
  • Figure 23: Europe Digital PCR Market Value (USD million), by End-user, 2025 & 2034
  • Figure 24: Europe Digital PCR Market Value Share (%), by End-user, 2025
  • Figure 25: Europe Digital PCR Market Value (USD million), By Country/ Sub-region, 2025 & 2034
  • Figure 26: Europe Digital PCR Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 27: Asia Pacific Digital PCR Market Value (USD million), by Type, 2025 & 2034
  • Figure 28: Asia Pacific Digital PCR Market Value Share (%), by Type, 2025
  • Figure 29: Asia Pacific Digital PCR Market Value (USD million), by Product, 2025 & 2034
  • Figure 30: Asia Pacific Digital PCR Market Value Share (%), by Product, 2025
  • Figure 31: Asia Pacific Digital PCR Market Value (USD million), by Indication, 2025 & 2034
  • Figure 32: Asia Pacific Digital PCR Market Value Share (%), by Indication, 2025
  • Figure 33: Asia Pacific Digital PCR Market Value (USD million), by End-user, 2025 & 2034
  • Figure 34: Asia Pacific Digital PCR Market Value Share (%), by End-user, 2025
  • Figure 35: Asia Pacific Digital PCR Market Value (USD million), By Country/ Sub-region, 2025 & 2034
  • Figure 36: Asia Pacific Digital PCR Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 37: Latin America Digital PCR Market Value (USD million), by Type, 2025 & 2034
  • Figure 38: Latin America Digital PCR Market Value Share (%), by Type, 2025
  • Figure 39: Latin America Digital PCR Market Value (USD million), by Product, 2025 & 2034
  • Figure 40: Latin America Digital PCR Market Value Share (%), by Product, 2025
  • Figure 41: Latin America Digital PCR Market Value (USD million), by Indication, 2025 & 2034
  • Figure 42: Latin America Digital PCR Market Value Share (%), by Indication, 2025
  • Figure 43: Latin America Digital PCR Market Value (USD million), by End-user, 2025 & 2034
  • Figure 44: Latin America Digital PCR Market Value Share (%), by End-user, 2025
  • Figure 45: Latin America Digital PCR Market Value (USD million), By Country/ Sub-region, 2025 & 2034
  • Figure 46: Latin America Digital PCR Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 47: Middle East & Africa Digital PCR Market Value (USD million), by Type, 2025 & 2034
  • Figure 48: Middle East & Africa Digital PCR Market Value Share (%), by Type, 2025
  • Figure 49: Middle East & Africa Digital PCR Market Value (USD million), by Product, 2025 & 2034
  • Figure 50: Middle East & Africa Digital PCR Market Value Share (%), by Product, 2025
  • Figure 51: Middle East & Africa Digital PCR Market Value (USD million), by Indication, 2025 & 2034
  • Figure 52: Middle East & Africa Digital PCR Market Value Share (%), by Indication, 2025
  • Figure 53: Middle East & Africa Digital PCR Market Value (USD million), by End-user, 2025 & 2034
  • Figure 54: Middle East & Africa Digital PCR Market Value Share (%), by End-user, 2025
  • Figure 55: Middle East & Africa Digital PCR Market Value (USD million), By Country/ Sub-region, 2025 & 2034
  • Figure 56: Middle East & Africa Digital PCR Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 57: Global Digital PCR Market Share (%), By Company, 2025